Tue, 07 May 2024 | BUSINESS SALE
Abingdon Health, a listed diagnostic test manufacturer based in York, has acquired IVDeology Holdings, a regulatory consultancy supporting the in vitro diagnostics sector. Abingdon Health has acquired the company for a total consideration of up to £700,000.
IVDeology is based in Maidstone and provides regulatory services supporting IVDR (the In Vitro Medical Devices Regulation (EU) 2017/746) for the EU market, UKCA (UK-Conformity Assessed)-marking for the UK market, and FDA support for the US market.
The company serves an international customer base and provides regulatory services including filing support, quality management system implementation, technical file build and quality assurance.
Abingdon Health plc will fund the acquisition by issuing five million ordinary shares to IVDeology’s owners at an issue price of 10 pence per share, equating to £500,000. An earn-out of £200,000 will be payable subject to the business achieving certain revenue targets in the two financial years post-acquisition.
In the year ending January 31 2024, IVDeology generated combined turnover of £392,000 across its three entities, recording a combined pre-tax loss of £30,000. Following the sale, the company will continue to be led by co-founders Stuart Angell and Nancy Consterdine (pictured above) as part of the wider Abingdon Health group.
Chris Yates, chief executive at Abingdon Health, said: "The acquisition of IVDeology is in line with Abingdon's strategy of providing our customers with all the pieces of the jigsaw required to bring products from idea to commercial success.”
"The IVDeology team will strengthen Abingdon's existing knowledge leadership and regulatory expertise. We look forward to working with the IVDeology team and supporting existing and new customers in navigating a regulatory environment going through a period of significant change."
Stuart Angell, co-founder and Managing Director at IVDeology, added: "The in vitro diagnostics sector is undergoing a significant period of regulatory change in the UK, EU and internationally. By combining our collective skills, knowledge, and expertise, we can support our customers and the wider IVD industry with the comprehensive service that this opportunity provides."
Find out more about how consultancy owners can make the most of growing M&A appetite for consulting firms
Astounding opportunity to purchase or invest in a world class product with global potential the only product in class with Adisa certified product assurance in the world world’s fastest product in it’s sector for sale. Product tested in conjunction w...
This business has an average household portfolio value in excess of £500,000, meaning you will be servicing a core group of profitable clients.
This business has an average on-going adviser charge of 0.5%, providing potential for future uplift.
Please choose your settings for this site below. For more information please read our Cookie Policy
These cookies are necessary for our website to function properly and provide you with access to all features.
These are analytics cookies that help us to improve the way our website works.
These are used to improve the functional performance of the website and make it easier for you to use.